Paper5051663
Results of treatment of malignant tumors with ftorafur.
Blokhina NG and 2 others. Cancer, 1972. Cited by 115 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Results of treatment of malignant tumors with ftorafur. Papers, record 5051663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5051663
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluorouracil | Major topic |
| Neoplasms | Major topic |
| Antimetabolites | |
| Antineoplastic Agents | |
| Brain Neoplasms | |
| Breast Neoplasms | |
| Colonic Neoplasms | |
| Deoxyribonucleosides | |
| Furans | |
| Humans | |
| Oligodendroglioma | |
| Pyrimidines | |
| Rectal Neoplasms | |
| Stomach Neoplasms | |
| USSR |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,396,765 | Crystal structures of 4-phenyl-piperazin-1-ium 6-chloro-5-ethyl-2,4-dioxopyrimidin-1-ide and 4-phenyl-piperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide. | Acta Crystallogr E Crystallogr Commun | 2015 | https://conductscience.org/library/papers/26396765 | PubMed |
| 24,764,966 | 4-(2-Meth-oxy-phen-yl)piperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide. | Acta Crystallogr Sect E Struct Rep Online | 2014 | https://conductscience.org/library/papers/24764966 | PubMed |
| 11,122,822 | Novel oral chemotherapy agents. | Curr Oncol Rep | 2000 | https://conductscience.org/library/papers/11122822 | PubMed |
| 10,510,136 | A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer. | Br J Clin Pharmacol | 1999 | https://conductscience.org/library/papers/10510136 | PubMed |
| 10,363,582 | p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer. | Jpn J Cancer Res | 1999 | https://conductscience.org/library/papers/10363582 | PubMed |
| 9,744,503 | Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9744503 | PubMed |
| 8,398,696 | In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-uracils; effects on thymidylate synthesis. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8398696 | PubMed |
| 7,623,069 | Clinical application of 18F-FUdR in glioma patients--PET study of nucleic acid metabolism. | J Neurooncol | 1995 | https://conductscience.org/library/papers/7623069 | PubMed |
| 6,813,336 | Chemotherapeutic studies on N-nitrosoacetoxymethyl-methylamine-and 1,2-dimethylhydrazine-induced colonic tumors in rats: monotherapy with 5-fluorouracil, ftorafur, CGP 6809, and CGP 15'720A. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/6813336 | PubMed |
| 6,792,409 | Comparative efficacy of antitumor treatment for liver metastases from colorectal cancer. | Jpn J Surg | 1981 | https://conductscience.org/library/papers/6792409 | PubMed |
| 6,182,702 | Palliative and adjunctive measures in rectal cancer. | World J Surg | 1982 | https://conductscience.org/library/papers/6182702 | PubMed |
| 3,090,050 | Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with L-cystine. | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3090050 | PubMed |
| 3,032,726 | Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma. | Gastroenterol Jpn | 1987 | https://conductscience.org/library/papers/3032726 | PubMed |
| 2,257,207 | Phase II trial of UFT in advanced colorectal and gastric cancer. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2257207 | PubMed |
| 2,109,630 | Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2109630 | PubMed |
| 1,760,854 | Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/1760854 | PubMed |
| 589,882 | Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy. | Clin Pharmacokinet | 1977 | https://conductscience.org/library/papers/589882 | PubMed |
| 155,503 | New drugs under clinical evaluation in the United States. | Cancer Chemother Pharmacol | 1978 | https://conductscience.org/library/papers/155503 | PubMed |
| 119,584 | Ftorafur: a self-limiting source of 5-fluorouracil? | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/119584 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5051663
GET https://conductscience.org/api/papers/v1/5051663/authors